Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.
Kevin L. Facchine, PhD
Advertisement
Kevin L. Facchine, PhD, is a team manager in the chemical development analytical sciences department at GlaxoSmithKline.
Articles by Kevin L. Facchine, PhD
Advertisement
Latest Updated Articles
- Available Guidance and Best Practices for Conducting Forced Degradation Studies
Published: February 1st 2002 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
PharmTech Weekly News Roundup — Week of October 27, 2025
4
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
5
